Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BIF NASDAQ:CAEP NASDAQ:OACC NASDAQ:SVCC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIFBoulder Growth & Income Fund$14.75$14.47$12.70▼$15.10$1.45B0.85103,021 shs81,946 shsCAEPCantor Equity Partners III$10.77-1.4%$0.00$10.30▼$11.09$333.93MN/A1.05 million shs226,935 shsOACCOaktree Acquisition Corp. III Life Sciences$10.43-0.1%$10.48$9.95▼$10.85$234.12MN/A24,498 shs16,410 shsSVCCStellar V Capital$10.23$0.00$9.95▼$10.31$221.07MN/A23,939 shsN/AThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIFBoulder Growth & Income Fund0.00%0.00%0.00%0.00%0.00%CAEPCantor Equity Partners III-1.37%+1.89%+1,076,999,900.00%+1,076,999,900.00%+1,076,999,900.00%OACCOaktree Acquisition Corp. III Life Sciences-0.10%+0.19%-1.51%+3.17%+1,042,999,900.00%SVCCStellar V Capital0.00%0.00%+1,022,999,900.00%+1,022,999,900.00%+1,022,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIFBoulder Growth & Income FundN/AN/AN/AN/AN/AN/AN/AN/ACAEPCantor Equity Partners IIIN/AN/AN/AN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ASVCCStellar V CapitalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIFBoulder Growth & Income Fund 0.00N/AN/AN/ACAEPCantor Equity Partners III 0.00N/AN/AN/AOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ASVCCStellar V Capital 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIFBoulder Growth & Income FundN/AN/AN/AN/AN/AN/ACAEPCantor Equity Partners IIIN/AN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ASVCCStellar V CapitalN/AN/AN/AN/A($0.01) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIFBoulder Growth & Income FundN/AN/A0.00∞N/AN/AN/AN/AN/ACAEPCantor Equity Partners IIIN/AN/A0.00∞N/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ASVCCStellar V Capital-$160KN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIFBoulder Growth & Income Fund$0.432.92%N/AN/AN/ACAEPCantor Equity Partners IIIN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ASVCCStellar V CapitalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIFBoulder Growth & Income FundN/AN/AN/ACAEPCantor Equity Partners IIIN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/ASVCCStellar V CapitalN/A5.345.34Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIFBoulder Growth & Income Fund11.78%CAEPCantor Equity Partners IIIN/AOACCOaktree Acquisition Corp. III Life SciencesN/ASVCCStellar V CapitalN/AInsider OwnershipCompanyInsider OwnershipBIFBoulder Growth & Income Fund0.15%CAEPCantor Equity Partners IIIN/AOACCOaktree Acquisition Corp. III Life SciencesN/ASVCCStellar V CapitalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIFBoulder Growth & Income FundN/A98.27 million98.12 millionNot OptionableCAEPCantor Equity Partners III230.58 millionN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/A22.42 millionN/AN/ASVCCStellar V Capital321.61 millionN/AN/ABIF, CAEP, OACC, and SVCC HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBIF, CAEP, OACC, and SVCC Company DescriptionsBoulder Growth & Income Fund NYSE:BIFBoulder Growth & Income Fund, Inc. operates as a non-diversified, closed-end management company. It primarily invests in domestic common stocks, warrants, corporate bonds, the United States treasury bills and repurchase agreements. The firm seeks to produce both income and long-term capital appreciation by investing in a portfolio of equity and debt securities. Boulder Growth & Income Fund is headquartered in Denver, CO.Cantor Equity Partners III NASDAQ:CAEP$10.77 -0.15 (-1.37%) As of 07/18/2025 04:00 PM EasternWe are a blank check company incorporated on November 11, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any discussions, directly or indirectly, with any business combination target regarding an initial business combination with our company. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including the financial services, digital assets, healthcare, real estate services, technology and software industries. Further, our efforts to identify a prospective target business will not be limited to any characteristics, although we expect to favor potential target companies with certain characteristics which include, but are not limited to, positive long term growth prospects, competitive advantages, consolidation opportunities, recurring revenue or the potential for recurring revenue, opportunities for operational improvement and attractive margins or the potential for attractive margins. Our executive offices are located New York, New York.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.43 -0.01 (-0.10%) As of 07/18/2025 03:32 PM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Stellar V Capital NASDAQ:SVCC$10.23 0.00 (0.00%) As of 07/18/2025We are a blank check company incorporated on July 12, 2024 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We may pursue an initial business combination target in any business or industry or at any stage of its corporate evolution. Our primary focus, however, will be in completing a business combination with an established business of scale poised for continued growth, led by a highly regarded management team. Our management team has an extensive track record of acquiring attractive assets at disciplined valuations, investing in growth while fostering financial discipline and improving business results. Our executive offices are located at 230 Park Avenue, Suite 1540, New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
